Alterations to stem cell vascularization and exosome production in microgravity for heart and skin tissue repair, from siobhan malany, PHD at micro-GRX, INC.
Ended Awarded Last action
- Contract number
- 80JSC025FA092
- Awardee
-
Redwire Space Technologies, Inc. UEI EYSXHJ3R7S53
- Awarding agency
-
Johnson Space Center
National Aeronautics and Space Administration
- Obligated
- $275,000
Award facts
- Contract value 100% obligated
- $275,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Greenville, IN 47124, USA
- Research
- SBIR Program Phase III Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $175,000 | |
| Original award | $100,000 |
About this award
Redwire Space Technologies, Inc. was awarded a $275,000 firm fixed-price delivery order by NASA's Johnson Space Center on March 20, 2025, to conduct research on alterations to stem cell vascularization and exosome production in microgravity for heart and skin tissue repair. The work, led by Dr. Siobhan Malany, represents a Phase III action under NASA's Small Business Innovation Research (SBIR) Program, which focuses on transitioning innovative technologies toward commercialization and operational deployment. The contract is not subject to any set-aside designation and will be performed in Greenville, Indiana, with an ultimate completion date of January 30, 2026.
This award reflects Redwire's established expertise in microgravity research and biomedical investigations conducted aboard the International Space Station. The company has demonstrated sustained capability in executing similar research initiatives, including prior work on vascular tissue studies and stem cell vascularization in space environments. The Phase III designation indicates this research has progressed beyond initial feasibility demonstration and is now focused on refinement and preparation for potential practical applications in regenerative medicine and tissue engineering, leveraging the unique advantages of the microgravity environment to advance therapeutic solutions for cardiac and dermal repair.
Quick answers
Who was awarded contract 80JSC025FA092?
80JSC025FA092 was awarded to Redwire Space Technologies, Inc. by Johnson Space Center (National Aeronautics and Space Administration) on March 20, 2025.
How much is contract 80JSC025FA092 worth?
The government has obligated $275,000 on 80JSC025FA092.
Is contract 80JSC025FA092 an order under another contract?
Yes. 80JSC025FA092 is a delivery order under NNJ15GU31B, an indefinite delivery contract.
Was contract 80JSC025FA092 competed?
The extent of competition for 80JSC025FA092 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award